In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

PTC Industries shares rose as much as 18 percent on Monday after global brokerage Goldman Sachs reiterated its "buy" rating on the stock following the company's March quarter earnings and projected an ...

PTC India Ltd, Zee Entertainment Enterprises Ltd and PI Industries saw their shares falling up to 9 per cent in Wednesday's trade, following their weak set of March quarter results. ZEE shares plunged ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...

DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

PTC Inc. (PTC) reported $893.8 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 42.7%. EPS of $3.47 for the same period compares to $1.54 a year ago.

PTC’s Q4 2025 EPS of $3.47 exceeded forecasts by 52.86%. Revenue reached $894 million, a 19.06% surprise over expectations. Stock price fell 1.07% in aftermarket trading. Free cash flow for the full ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The premium tax credit is a refundable credit that helps some taxpayers afford health insurance premiums. The advance PTC lowers the premiums themselves. Many, or all, of the products featured on this ...

NHPC is unwilling to sell its stake in the power trading joint venture although it had, while shelving its buyout plan, said power trading was not its core business. New Delhi: After NHPC Ltd dropped ...

Aug 19 (Reuters) - The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' (PTCT.O), opens new tab oral medication for a rare genetic disorder with limited treatment options, ...